CIK 0001631574 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2021 | FY2020 | |
|---|---|---|---|---|
| Revenue (USD) | 42.7 M | 3.6 M | ||
| Net income (USD) | -149.9 M | -193.6 M | ||
| Diluted EPS (USD/shares) | -1.21 | -2.05 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-14 | ARS | ARS | 2025-12-31 |
| 2026-10-14 | DEF 14A | DEF 14A | 2026-11-12 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-08-14 | EFFECT | EFFECT items ,, | |
| 2026-08-13 | 4 | 4 | 2026-08-11 |
| 2026-08-13 | 4 | 4 | 2026-08-12 |
| 2026-08-13 | 4 | 4 | 2026-08-11 |
| 2026-08-13 | 4 | 4 | 2026-08-11 |
| 2026-08-12 | 144 | 144 | |
| 2026-08-11 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-10 | 15-12G | 15-12G | |
| 2026-08-10 | POS AM | POS AM | |
| 2026-08-10 | POSASR | POSASR | |
| 2026-08-10 | S-8 POS | S-8 POS | |
| 2026-08-10 | S-8 POS | S-8 POS | |
| 2026-08-10 | S-8 POS | S-8 POS | |
| 2026-08-10 | S-8 POS | S-8 POS |
Forms on file (last 1,000): 4 247, 8-K 155, SC 13G/A 40, 10-Q 33, 144 31, 3 25, SC 13G 23, S-8 POS 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=WVE (0.002 USD), /gw/filings/filings?ticker=WVE&form=8-K, /gw/filings/facts?ticker=WVE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange